pharmaceuticals-and-healthcare

United States RNA Analysis/Transcriptomics Market Report 2016


Published On : Oct 2016

Category : Biotechnology

No. of Pages : 119 pages

  • $3800
  • $7600

Please click below to avail discount on this report

Notes:
Sales, means the sales volume of RNA Analysis/Transcriptomics
Revenue, means the sales value of RNA Analysis/Transcriptomics

This report studies sales (consumption) of RNA Analysis/Transcriptomics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Affymetrix Inc. (U.S.)
Agilent Technologies Inc. (U.S.)
Bio-Rad Laboratories Inc. (U.S.)
GE Healthcare (U.S.)
Illumina Inc. (U.S.)
Qiagen N.V. (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Sigma Aldrich (U.S.)
Fluidigm Corporation (U.S.)
Thermofisher Scientific Inc. (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Microarray
PCR
Sequencing
RNAi Gene Silencing
Split by applications, this report focuses on sales, market share and growth rate of RNA Analysis/Transcriptomics in each application, can be divided into
Clinical Diagnostics
Drug Discovery
Toxicogenomics

A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side.

The United states rna analysistranscriptomics market report 2016 is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on.

The regional examination of the United states rna analysistranscriptomics market report 2016 can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years.

The competitive analysis presented in the report on the United states rna analysistranscriptomics market report 2016 can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

Table of Contents

United States RNA Analysis/Transcriptomics Market Report 2016
1 RNA Analysis/Transcriptomics Overview
1.1 Product Overview and Scope of RNA Analysis/Transcriptomics
1.2 Classification of RNA Analysis/Transcriptomics
1.2.1 Microarray
1.2.2 PCR
1.2.3 Sequencing
1.2.4 RNAi Gene Silencing
1.3 Application of RNA Analysis/Transcriptomics
1.3.1 Clinical Diagnostics
1.3.2 Drug Discovery
1.3.3 Toxicogenomics
1.4 United States Market Size Sales (Value) and Revenue (Volume) of RNA Analysis/Transcriptomics (2011-2021)
1.4.1 United States RNA Analysis/Transcriptomics Sales and Growth Rate (2011-2021)
1.4.2 United States RNA Analysis/Transcriptomics Revenue and Growth Rate (2011-2021)

2 United States RNA Analysis/Transcriptomics Competition by Manufacturers
2.1 United States RNA Analysis/Transcriptomics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States RNA Analysis/Transcriptomics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States RNA Analysis/Transcriptomics Average Price by Manufactures (2015 and 2016)
2.4 RNA Analysis/Transcriptomics Market Competitive Situation and Trends
2.4.1 RNA Analysis/Transcriptomics Market Concentration Rate
2.4.2 RNA Analysis/Transcriptomics Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States RNA Analysis/Transcriptomics Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States RNA Analysis/Transcriptomics Sales and Market Share by Type (2011-2016)
3.2 United States RNA Analysis/Transcriptomics Revenue and Market Share by Type (2011-2016)
3.3 United States RNA Analysis/Transcriptomics Price by Type (2011-2016)
3.4 United States RNA Analysis/Transcriptomics Sales Growth Rate by Type (2011-2016)

4 United States RNA Analysis/Transcriptomics Sales (Volume) by Application (2011-2016)
4.1 United States RNA Analysis/Transcriptomics Sales and Market Share by Application (2011-2016)
4.2 United States RNA Analysis/Transcriptomics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States RNA Analysis/Transcriptomics Manufacturers Profiles/Analysis
5.1 Affymetrix Inc. (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Affymetrix Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Agilent Technologies Inc. (U.S.)
5.2.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Agilent Technologies Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Bio-Rad Laboratories Inc. (U.S.)
5.3.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Bio-Rad Laboratories Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 GE Healthcare (U.S.)
5.4.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 GE Healthcare (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Illumina Inc. (U.S.)
5.5.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Illumina Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Qiagen N.V. (Germany)
5.6.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Qiagen N.V. (Germany) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 F. Hoffmann-La Roche Ltd. (Switzerland)
5.7.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 F. Hoffmann-La Roche Ltd. (Switzerland) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Sigma Aldrich (U.S.)
5.8.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Sigma Aldrich (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Fluidigm Corporation (U.S.)
5.9.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Fluidigm Corporation (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Thermofisher Scientific Inc. (U.S.)
5.10.2 RNA Analysis/Transcriptomics Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Thermofisher Scientific Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview

6 RNA Analysis/Transcriptomics Manufacturing Cost Analysis
6.1 RNA Analysis/Transcriptomics Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of RNA Analysis/Transcriptomics

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 RNA Analysis/Transcriptomics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of RNA Analysis/Transcriptomics Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States RNA Analysis/Transcriptomics Market Forecast (2016-2021)
10.1 United States RNA Analysis/Transcriptomics Sales, Revenue Forecast (2016-2021)
10.2 United States RNA Analysis/Transcriptomics Sales Forecast by Type (2016-2021)
10.3 United States RNA Analysis/Transcriptomics Sales Forecast by Application (2016-2021)
10.4 RNA Analysis/Transcriptomics Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Tables and Figures

Figure Picture of RNA Analysis/Transcriptomics
Table Classification of RNA Analysis/Transcriptomics
Figure United States Sales Market Share of RNA Analysis/Transcriptomics by Type in 2015
Figure Microarray Picture
Figure PCR Picture
Figure Sequencing Picture
Figure RNAi Gene Silencing Picture
Table Application of RNA Analysis/Transcriptomics
Figure United States Sales Market Share of RNA Analysis/Transcriptomics by Application in 2015
Figure Clinical Diagnostics Examples
Figure Drug Discovery Examples
Figure Toxicogenomics Examples
Figure United States RNA Analysis/Transcriptomics Sales and Growth Rate (2011-2021)
Figure United States RNA Analysis/Transcriptomics Revenue and Growth Rate (2011-2021)
Table United States RNA Analysis/Transcriptomics Sales of Key Manufacturers (2015 and 2016)
Table United States RNA Analysis/Transcriptomics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 RNA Analysis/Transcriptomics Sales Share by Manufacturers
Figure 2016 RNA Analysis/Transcriptomics Sales Share by Manufacturers
Table United States RNA Analysis/Transcriptomics Revenue by Manufacturers (2015 and 2016)
Table United States RNA Analysis/Transcriptomics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States RNA Analysis/Transcriptomics Revenue Share by Manufacturers
Table 2016 United States RNA Analysis/Transcriptomics Revenue Share by Manufacturers
Table United States Market RNA Analysis/Transcriptomics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market RNA Analysis/Transcriptomics Average Price of Key Manufacturers in 2015
Figure RNA Analysis/Transcriptomics Market Share of Top 3 Manufacturers
Figure RNA Analysis/Transcriptomics Market Share of Top 5 Manufacturers
Table United States RNA Analysis/Transcriptomics Sales by Type (2011-2016)
Table United States RNA Analysis/Transcriptomics Sales Share by Type (2011-2016)
Figure United States RNA Analysis/Transcriptomics Sales Market Share by Type in 2015
Table United States RNA Analysis/Transcriptomics Revenue and Market Share by Type (2011-2016)
Table United States RNA Analysis/Transcriptomics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of RNA Analysis/Transcriptomics by Type (2011-2016)
Table United States RNA Analysis/Transcriptomics Price by Type (2011-2016)
Figure United States RNA Analysis/Transcriptomics Sales Growth Rate by Type (2011-2016)
Table United States RNA Analysis/Transcriptomics Sales by Application (2011-2016)
Table United States RNA Analysis/Transcriptomics Sales Market Share by Application (2011-2016)
Figure United States RNA Analysis/Transcriptomics Sales Market Share by Application in 2015
Table United States RNA Analysis/Transcriptomics Sales Growth Rate by Application (2011-2016)
Figure United States RNA Analysis/Transcriptomics Sales Growth Rate by Application (2011-2016)
Table Affymetrix Inc. (U.S.) Basic Information List
Table Affymetrix Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Affymetrix Inc. (U.S.) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table Agilent Technologies Inc. (U.S.) Basic Information List
Table Agilent Technologies Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies Inc. (U.S.) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table Bio-Rad Laboratories Inc. (U.S.) Basic Information List
Table Bio-Rad Laboratories Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio-Rad Laboratories Inc. (U.S.) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table GE Healthcare (U.S.) Basic Information List
Table GE Healthcare (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare (U.S.) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table Illumina Inc. (U.S.) Basic Information List
Table Illumina Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina Inc. (U.S.) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table Qiagen N.V. (Germany) Basic Information List
Table Qiagen N.V. (Germany) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qiagen N.V. (Germany) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table Sigma Aldrich (U.S.) Basic Information List
Table Sigma Aldrich (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sigma Aldrich (U.S.) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table Fluidigm Corporation (U.S.) Basic Information List
Table Fluidigm Corporation (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fluidigm Corporation (U.S.) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table Thermofisher Scientific Inc. (U.S.) Basic Information List
Table Thermofisher Scientific Inc. (U.S.) RNA Analysis/Transcriptomics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermofisher Scientific Inc. (U.S.) RNA Analysis/Transcriptomics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA Analysis/Transcriptomics
Figure Manufacturing Process Analysis of RNA Analysis/Transcriptomics
Figure RNA Analysis/Transcriptomics Industrial Chain Analysis
Table Raw Materials Sources of RNA Analysis/Transcriptomics Major Manufacturers in 2015
Table Major Buyers of RNA Analysis/Transcriptomics
Table Distributors/Traders List
Figure United States RNA Analysis/Transcriptomics Production and Growth Rate Forecast (2016-2021)
Figure United States RNA Analysis/Transcriptomics Revenue and Growth Rate Forecast (2016-2021)
Table United States RNA Analysis/Transcriptomics Production Forecast by Type (2016-2021)
Table United States RNA Analysis/Transcriptomics Consumption Forecast by Application (2016-2021)

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top